insights_auto
Kwa nini KROS imeongezeka kwa 2.18%?
Fahamu zaidichevron_right
KROS:NASDAQ
Keros Therapeutics Inc
US$ 10.30
arrow_upward
+2.18%(+0.22) Siku 1
13 Nov, 16:00:00 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya KROS...
Fungua
US$ 10.06
Juu
US$ 10.55
Chini
US$ 9.55
Mtaji wa soko
202.13M
Wastani wa kiasi cha mauzo
elfu 186.70
Kiasi cha mauzo ya hisa
elfu 167.04
Juu kwa wiki 52
US$ 22.55
Chini kwa wiki 52
US$ 8.98
EPS
-US$ 2.83
Beta
1.13
Hisa za wawekezaji
19.62M
Idadi ya wafanyakazi
87
Fungua
US$ 10.06
Juu
US$ 10.55
Chini
US$ 9.55
Mtaji wa soko
202.13M
Wastani wa kiasi cha mauzo
elfu 186.70
Kiasi cha mauzo ya hisa
elfu 167.04
Juu kwa wiki 52
US$ 22.55
Chini kwa wiki 52
US$ 8.98
EPS
-US$ 2.83
Beta
1.13
Hisa za wawekezaji
19.62M
Idadi ya wafanyakazi
87
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TradingView
·
saa 7 zilizopita
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
24/7 Wall St.
·
saa 2 zilizopita
He Thinks His $200,000 S&P 500 401(k) Spreads His AI Risk. Two Alphabet Share Classes Put $10,380 in One Company. A 20% Drop Could Cost Him $2,076
Bloomberg.com
·
saa 12 zilizopita
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
Traders Union
·
saa 6 zilizopita
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Kuhusu Keros Therapeutics Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi87
Lilianzishwa2015
Makao makuuLexington, Massachusetts, Marekani
SektaHealth Care
Sekta-
Tovutikerostx.com